Sartans API Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Valsartan, Irbesartan, Telmisartan, Losartan, Others); Applications (Anti-Hypertension, Anti-Viral, Others),Impact of covid-19 pandemic.
Report Code: TIPRE00015289 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Sartans acts as an angiotensin receptor antagonists that helps in blocking the action of angiotensin that allows the dilation of blood vessels. Angiotensin are the chemicals in the human body that affect the heart by narrowing down the blood vessels that do not allow the required space to the blood to move, resulting in increasing blood pressure, also called as hypertension, and cardiovascular risks. Leading brands in the Sartans API market include Benicar (olmesartan medoxomil), Diovan (valsartan), Micardis (telmisartan), Cozaar (Osartan), EdSartans APIi (Azilsartan), Atacand (candesartan), Teveten (eprosartan), and Avapro (irbesartan). Sartans APIs help in the treatment of conditions, such as, high blood pressure, cardiac failure, chronic kidney diseases, and kidney failure in diabetes.
MARKET DYNAMICS
Market for Sartans API market is driving due to factors such as increasing prevalence of hypertension, cardiovascular disorders and kidney failure in diabetics, increasing geriatric population and commercial availability of Sartans as generic medicines. However, stringent government regulations associated with manufacturing of APIs and strong competition in generic market is expected to hamper the market growth.
MARKET SCOPE
The Sartans API market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Sartans API market with detailed market segmentation by product and application. The Sartans API market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Sartans API market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Sartans API market is segmented on the basis of product and application. Based on product, the market is segmented as Valsartan, Irbesartan, Telmisartan, Losartan, others. Based on application, market is segmented as Anti-Hypertension, Anti-Viral, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Sartans API market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Sartans API market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Sartans API market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Sartans API market in these regions.
The report covers key developments in the Sartans API market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Sartans API market are anticipated to have lucrative growth opportunities in the future with the rising demand for Sartans API in the global market. Below mentioned is the list of few companies engaged in the Sartans API market.
The report also includes the profiles of key players in Sartans API market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Sartans acts as an angiotensin receptor antagonists that helps in blocking the action of angiotensin that allows the dilation of blood vessels. Angiotensin are the chemicals in the human body that affect the heart by narrowing down the blood vessels that do not allow the required space to the blood to move, resulting in increasing blood pressure, also called as hypertension, and cardiovascular risks. Leading brands in the Sartans API market include Benicar (olmesartan medoxomil), Diovan (valsartan), Micardis (telmisartan), Cozaar (Osartan), EdSartans APIi (Azilsartan), Atacand (candesartan), Teveten (eprosartan), and Avapro (irbesartan). Sartans APIs help in the treatment of conditions, such as, high blood pressure, cardiac failure, chronic kidney diseases, and kidney failure in diabetes.
MARKET DYNAMICS
Market for Sartans API market is driving due to factors such as increasing prevalence of hypertension, cardiovascular disorders and kidney failure in diabetics, increasing geriatric population and commercial availability of Sartans as generic medicines. However, stringent government regulations associated with manufacturing of APIs and strong competition in generic market is expected to hamper the market growth.
MARKET SCOPE
The Sartans API market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Sartans API market with detailed market segmentation by product and application. The Sartans API market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Sartans API market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Sartans API market is segmented on the basis of product and application. Based on product, the market is segmented as Valsartan, Irbesartan, Telmisartan, Losartan, others. Based on application, market is segmented as Anti-Hypertension, Anti-Viral, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Sartans API market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Sartans API market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Sartans API market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Sartans API market in these regions.
The report covers key developments in the Sartans API market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Sartans API market are anticipated to have lucrative growth opportunities in the future with the rising demand for Sartans API in the global market. Below mentioned is the list of few companies engaged in the Sartans API market.
The report also includes the profiles of key players in Sartans API market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer
- Novartis
- Merck
- AstraZeneca
- Eli Lilly
- Sanofi
- Bristol-Myers Squibb
- Bayer
- Huahai Pharmaceutical
- Teva Pharmaceutical
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Pfizer
2. Novartis
3. Merck
4. AstraZeneca
5. Eli Lilly
6. Sanofi
7. Bristol-Myers Squibb
8. Bayer
9. Huahai Pharmaceutical
10. Teva Pharmaceutical
1. Pfizer
2. Novartis
3. Merck
4. AstraZeneca
5. Eli Lilly
6. Sanofi
7. Bristol-Myers Squibb
8. Bayer
9. Huahai Pharmaceutical
10. Teva Pharmaceutical
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount